Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features

Area of Science:

• Hepatology
• Immunology
• Internal Medicine

Background:

• Autoimmune hepatitis (AIH) is a chronic liver disease of unknown etiology.
• Diagnosis relies on a combination of clinical, biochemical, immunological, and histological features.
• Exclusion of other liver diseases is paramount for accurate AIH diagnosis.

Purpose of the Study:

• To highlight key diagnostic considerations in autoimmune hepatitis.
• To emphasize the importance of histological confirmation and specific autoantibody testing.
• To discuss the limitations of biochemical markers and classification systems in clinical management.

Main Methods:

• Review of diagnostic criteria for autoimmune hepatitis.
• Emphasis on histological assessment by hepatopathologists.
• Discussion of serological markers, including conventional autoantibodies and anti-LKM1.
• Evaluation of biochemical parameters and autoantibody titers for disease activity monitoring.
• Analysis of existing classification systems for AIH.

Main Results:

• Histological confirmation by an experienced hepatopathologist is recommended whenever possible.
• Seronegativity for conventional autoantibodies does not rule out AIH.
• Testing for anti-LKM1 antibodies is essential to detect type 2 AIH.
• Biochemical abnormalities and autoantibody titers are not fully reliable indicators of disease activity.
• Current classification systems are useful for research but not definitive for individual patient management.

Conclusions:

• Accurate diagnosis of AIH necessitates a comprehensive approach, including exclusion of other liver diseases and potential histological confirmation.
• Specific autoantibody testing, particularly for anti-LKM1, is critical for identifying all forms of AIH.
• Clinical management of AIH should be individualized, considering the limitations of current monitoring tools and classification systems.